Company

Vysioneer

Rocket Ship Rating

Rocket Ship Rating: 81 out of 100

Unlocking lesion-level insights to make oncology trials smaller and faster

Health IT
Medical devices & diagnostics
AI native

Status: Operatingas of 2026-09-18
Business model: B2B
Headquarters: Cambridge, MA, United States
Customers: pharma and clinicians

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Vysioneer is an oncology AI company with a mission to use machine learning to bring therapies to cancer patients in need sooner.

Funding snapshot

Total raised: $2.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $750K2023-06-01

Funding rounds

Round, 2023: $750K2023-06-01, SEC form D sold, 1 investor
Round, 2020: $1.5M2020-12-31, SEC form D sold, 5 investors
Round, 2019: $500K2019-09-03, SEC form D sold, 6 investors